Leukogene Therapeutics
Pre-clinicalLeukogene Therapeutics, Inc. is a cancer biotherapeutics company delivering innovative immunotherapies for patients living with cancer. Our MHC class II targeted M2T™ immunotherapies direct and mobilize the immune system to eliminate tumor cells.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Funding information not available
About
Leukogene Therapeutics, Inc. is a cancer biotherapeutics company delivering innovative immunotherapies for patients living with cancer. Our MHC class II targeted M2T™ immunotherapies direct and mobilize the immune system to eliminate tumor cells.
Biologics